- EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex2016 | 2. lékařská fakulta
- Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma2015 | 3. lékařská fakulta
- Gefinitib (ZD 1839, Iressa(R)) in treatment of advanced non-small cell lung cancers - one institutional experience on an expanded access programPublikace bez příslušnosti k fakultě
- Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting2019 | Publikace bez příslušnosti k fakultě
- Melanoma antigens are biomarkers for ipilimumab response2017 | 3. lékařská fakulta, Ústřední knihovna